Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HRMY · as of Jun 8, 2026
Key Statistics
Explore Harmony Biosciences Holdings, Inc. Data
hrmy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 69.2%
The HRMY analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $43.00, representing +33.54% upside from the current price of $32.20.
Competitors & Peers
hrmy competitorsHRMY
ABCL
AUPH
BHVN
CLDX
IMCRStock Performance
Full HistoryAbout Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WA…
what is harmony biosciences holdings, inc. · hrmy stock overview · harmony biosciences holdings, inc. company profile · who is harmony biosciences holdings, inc. ceo · hrmy NASDAQ · harmony biosciences holdings, inc. headquarters · harmony biosciences holdings, inc. business segments
About Stock Overview & Key Data
Harmony Biosciences Holdings, Inc. (HRMY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 19, 2020. As of the latest trading session, HRMY stock price is $32.20, with a market capitalization of $1.9B. The stock has returned -9.09% over the past 12 months and -13.95% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Harmony Biosciences Holdings, Inc. stock is Buy, with an average 12-month price target of $43.00. In fiscal year 2025, Harmony Biosciences Holdings, Inc. reported revenue of $868.5M and net income of $158.7M. For detailed data — including Harmony Biosciences Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Harmony Biosciences Holdings, Inc. (HRMY) stock price is $32.20. The stock is traded on NASDAQ under the ticker symbol HRMY. The 52-week range is $25.52 – $40.87.